Moleculin Biotech, INC. (MBRX) — 8-K Filings

All 8-K filings from Moleculin Biotech, INC.. Browse 39 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (39)

Moleculin Biotech Enters Material Definitive Agreement — Dec 22, 2025 Risk: medium
On December 21, 2025, Moleculin Biotech, Inc. entered into a material definitive agreement. The company, headquartered in Houston, TX, filed an 8-K report detai
Moleculin Biotech Files 8-K — Dec 17, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on December 17, 2025, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD Discl
Moleculin Biotech Files 8-K — Dec 16, 2025 Risk: low
On December 15, 2025, Moleculin Biotech, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 5300 Memorial D
Moleculin Biotech Files 8-K: Material Agreement & Equity Sales — Dec 10, 2025 Risk: medium
On December 9, 2025, Moleculin Biotech, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities
8-K Filing — Dec 9, 2025
8-K Filing — Dec 8, 2025
8-K Filing — Nov 28, 2025
Moleculin Biotech Files 8-K — Nov 24, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on November 24, 2025, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD Discl
8-K Filing — Nov 21, 2025
8-K Filing — Nov 12, 2025
Moleculin Biotech Files 8-K with Corporate Updates — Oct 30, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on October 30, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the com
Moleculin Biotech Files 8-K Report — Oct 29, 2025 Risk: low
On October 29, 2025, Moleculin Biotech, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits.
Moleculin Biotech Files 8-K — Oct 23, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on October 23, 2025, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD Disclo
Moleculin Biotech Files 8-K on Security Holder Vote — Oct 16, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on October 16, 2025, reporting on the submission of matters to a vote of security holders. The filing details the company's
Moleculin Biotech Files 8-K Report — Sep 25, 2025 Risk: low
On September 25, 2025, Moleculin Biotech, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits
Moleculin Biotech Files 8-K with Exhibits — Sep 9, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on September 9, 2025, reporting on events that occurred on the same date. The filing includes financial statements and exhi
Moleculin Biotech Files 8-K with Corporate Updates — Sep 8, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on September 8, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the
Moleculin Biotech Files 8-K: Material Agreement & Equity Sales — Aug 29, 2025 Risk: medium
Moleculin Biotech, Inc. announced on August 28, 2025, that it entered into a material definitive agreement. The company also disclosed unregistered sales of equ
Moleculin Biotech Files 8-K with Corporate Updates — Aug 27, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on August 27, 2025, reporting an event on August 21, 2025. The filing indicates amendments to its Articles of Incorporation
Moleculin Biotech Files 8-K on Shareholder Votes — Aug 18, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on August 18, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corp
Moleculin Biotech Files 8-K on Financials — Aug 13, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on August 13, 2025, reporting on its results of operations and financial condition. The filing includes financial statement
Moleculin Biotech Files 8-K with Financials and Disclosures — Aug 6, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on August 6, 2025, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the co
Moleculin Biotech Files 8-K Current Report — Aug 1, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on August 1, 2025, reporting an event that occurred on the same date. The filing is a current report pursuant to Section 13
Moleculin Biotech Files 8-K — Jul 30, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on July 30, 2025, reporting on financial statements and exhibits. The filing does not appear to contain new material events
Moleculin Biotech Files 8-K with Corporate Updates — Jul 17, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on July 17, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the com
Moleculin Biotech Files 8-K: Material Agreement & Exhibits — Jul 11, 2025 Risk: medium
On July 11, 2025, Moleculin Biotech, Inc. filed an 8-K report. The filing indicates the company entered into a material definitive agreement and also includes f
Moleculin Biotech Files 8-K Report — Jul 9, 2025 Risk: low
On July 9, 2025, Moleculin Biotech, Inc. filed an 8-K report. The filing indicates that the company is providing information related to Regulation FD Disclosure
Moleculin Biotech Faces Delisting Concerns — Jun 27, 2025 Risk: high
Moleculin Biotech, Inc. filed an 8-K on June 27, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company is incorporat
Moleculin Biotech Files 8-K: Material Agreement & Financials — Jun 23, 2025 Risk: medium
On June 20, 2025, Moleculin Biotech, Inc. entered into a material definitive agreement. The company also disclosed information related to Regulation FD and file
Moleculin Biotech Files 8-K: Financials & Other Events — Jun 18, 2025 Risk: low
On June 18, 2025, Moleculin Biotech, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and other events, indicating pot
Moleculin Biotech Files 8-K with Financials — Jun 5, 2025 Risk: low
On June 5, 2025, Moleculin Biotech, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating updates or disclosures
Moleculin Biotech Files 8-K — Jun 4, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on June 4, 2025, reporting on events that occurred on the same date. The filing includes financial statements and exhibits,
Moleculin Biotech Faces Delisting Concerns — May 23, 2025 Risk: high
Moleculin Biotech, Inc. filed an 8-K on May 23, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company, i
Moleculin Biotech Files 8-K on Operations and Financials — May 14, 2025 Risk: low
On May 14, 2025, Moleculin Biotech, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well
Moleculin Biotech Files 8-K — May 12, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on May 12, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain sp
Moleculin Biotech Files 8-K on Shareholder Votes — May 9, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on May 9, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corporat
Moleculin Biotech Files 8-K — May 7, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on May 7, 2025, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD Disclosure
Moleculin Biotech Files 8-K — May 6, 2025 Risk: low
On May 6, 2025, Moleculin Biotech, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No sp
Moleculin Biotech Files 8-K with Corporate Updates — May 5, 2025 Risk: low
Moleculin Biotech, Inc. filed an 8-K on May 5, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company'

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX